Search results for "clinical trials"

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy. A new study indicates that patients with...
Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third

Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third

"I’m taking my medication faithfully—so why is this happening again?" It is a deeply frustrating question that patients with depression or bipolar...
Study: Migraine shot cuts headache days by half for 70% of older patients after a year

Study: Migraine shot cuts headache days by half for 70% of older patients after a year

"Mom, another headache? Go to the hospital and try the shot." "Is it OK for someone my age to get such an expensive...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
Umbilical Cord-Derived Stem Cell Therapy Offers New Hope for Treatment-Resistant Hair Loss

Umbilical Cord-Derived Stem Cell Therapy Offers New Hope for Treatment-Resistant Hair Loss

For many individuals experiencing hair loss, investing significant time and money into treatments does not always...
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence

"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...